Literature DB >> 28657550

Pre-treatment patient-specific stopping power by combining list-mode proton radiography and x-ray CT.

Charles-Antoine Collins-Fekete1, Sébastien Brousmiche, David C Hansen, Luc Beaulieu, Joao Seco.   

Abstract

The relative stopping power (RSP) uncertainty is the largest contributor to the range uncertainty in proton therapy. The purpose of this work was to develop a systematic method that yields accurate and patient-specific RSPs by combining (1) pre-treatment x-ray CT and (2) daily proton radiography of the patient. The method was formulated as a penalized least squares optimization problem (argmin([Formula: see text])). The parameter A represents the cumulative path-length crossed by the proton in each material, separated by thresholding on the HU. The material RSPs (water equivalent thickness/physical thickness) are denoted by x. The parameter b is the list-mode proton radiography produced using Geant4 simulations. The problem was solved using a non-negative linear-solver with [Formula: see text]. A was computed by superposing proton trajectories calculated with a cubic or linear spline approach to the CT. The material's RSP assigned in Geant4 were used for reference while the clinical HU-RSP calibration curve was used for comparison. The Gammex RMI-467 phantom was first investigated. The standard deviation between the estimated material RSP and the calculated RSP is 0.45%. The robustness of the techniques was then assessed as a function of the number of projections and initial proton energy. Optimization with two initial projections yields precise RSP (⩽1.0%) for 330 MeV protons. 250 MeV protons have shown higher uncertainty (⩽2.0%) due to the loss of precision in the path estimate. Anthropomorphic phantoms of the head, pelvis, and lung were subsequently evaluated. Accurate RSP has been obtained for the head ([Formula: see text]), the lung ([Formula: see text]) and the pelvis ([Formula: see text]). The range precision has been optimized using the calibration curves obtained with the algorithm, yielding a mean [Formula: see text] difference to the reference of 0.11  ±0.09%, 0.28  ±  0.34% and [Formula: see text] in the same order. The solution's accuracy is limited by the assumed HU/RSP bijection, neglecting inherent degeneracy. The proposed formulation of the problem with prior knowledge x-ray CT demonstrates potential to increase the accuracy of present RSP estimates.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28657550     DOI: 10.1088/1361-6560/aa7c42

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  6 in total

Review 1.  Status and innovations in pre-treatment CT imaging for proton therapy.

Authors:  Patrick Wohlfahrt; Christian Richter
Journal:  Br J Radiol       Date:  2019-11-11       Impact factor: 3.039

2.  A comparison of proton stopping power measured with proton CT and x-ray CT in fresh postmortem porcine structures.

Authors:  Don F DeJongh; Ethan A DeJongh; Victor Rykalin; Greg DeFillippo; Mark Pankuch; Andrew W Best; George Coutrakon; Kirk L Duffin; Nicholas T Karonis; Caesar E Ordoñez; Christina Sarosiek; Reinhard W Schulte; John R Winans; Alec M Block; Courtney L Hentz; James S Welsh
Journal:  Med Phys       Date:  2021-11-18       Impact factor: 4.071

3.  The accuracy of helium ion CT based particle therapy range prediction: an experimental study comparing different particle and x-ray CT modalities.

Authors:  L Volz; C-A Collins-Fekete; E Bär; S Brons; C Graeff; R P Johnson; A Runz; C Sarosiek; R W Schulte; J Seco
Journal:  Phys Med Biol       Date:  2021-11-29       Impact factor: 3.609

Review 4.  Latest developments in in-vivo imaging for proton therapy.

Authors:  Katia Parodi
Journal:  Br J Radiol       Date:  2019-12-12       Impact factor: 3.039

5.  Laser-driven x-ray and proton micro-source and application to simultaneous single-shot bi-modal radiographic imaging.

Authors:  T M Ostermayr; C Kreuzer; F S Englbrecht; J Gebhard; J Hartmann; A Huebl; D Haffa; P Hilz; K Parodi; J Wenz; M E Donovan; G Dyer; E Gaul; J Gordon; M Martinez; E Mccary; M Spinks; G Tiwari; B M Hegelich; J Schreiber
Journal:  Nat Commun       Date:  2020-12-02       Impact factor: 14.919

Review 6.  Considerations for Upright Particle Therapy Patient Positioning and Associated Image Guidance.

Authors:  Lennart Volz; Yinxiangzi Sheng; Marco Durante; Christian Graeff
Journal:  Front Oncol       Date:  2022-07-29       Impact factor: 5.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.